PRO DEX INCPDEXEarnings & Financial Report
Pro Dex Inc is a precision manufacturing enterprise that produces custom machined components, subassemblies and finished products primarily for medical device original equipment manufacturers, as well as clients in the aerospace and industrial sectors, with its core operating market covering North America.
Revenue
$17.4M
Gross Profit
$5.8M
Operating Profit
$3.6M
Net Profit
$3.3M
Gross Margin
33.3%
Operating Margin
20.9%
Net Margin
18.8%
YoY Growth
21.8%
EPS
$0.98
PRO DEX INC Q3 FY2025 Financial Summary
PRO DEX INC reported revenue of $17.4M (up 21.8% YoY) for Q3 FY2025, with a net profit of $3.3M (up 400.0% YoY) (18.8% margin). Cost of goods sold was $11.6M, operating expenses totaled $2.2M.
Key Financial Metrics
| Total Revenue | $17.4M |
|---|---|
| Net Profit | $3.3M |
| Gross Margin | 33.3% |
| Operating Margin | 20.9% |
| Report Period | Q3 FY2025 |
PRO DEX INC Annual Revenue by Year
PRO DEX INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $66.6M).
| Year | Annual Revenue |
|---|---|
| 2025 | $66.6M |
| 2024 | $53.8M |
| 2023 | $46.1M |
| 2022 | $42.0M |
PRO DEX INC Quarterly Revenue & Net Profit History
PRO DEX INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $18.7M | +11.1% | $2.2M | 11.7% |
| Q1 FY2026 | $18.5M | +24.4% | $4.7M | 25.3% |
| Q4 FY2025 | $17.5M | +16.4% | $1.2M | 6.8% |
| Q3 FY2025 | $17.4M | +21.8% | $3.3M | 18.8% |
| Q2 FY2025 | $16.8M | +33.4% | $2.0M | 12.1% |
| Q1 FY2025 | $14.9M | +24.7% | $2.5M | 16.6% |
| Q4 FY2024 | $15.0M | +41.2% | $1.6M | 10.6% |
| Q3 FY2024 | $14.3M | +9.3% | $655.0K | 4.6% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.3M | $15.0M | $14.9M | $16.8M | $17.4M | $17.5M | $18.5M | $18.7M |
| YoY Growth | 9.3% | 41.2% | 24.7% | 33.4% | 21.8% | 16.4% | 24.4% | 11.1% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $50.5M | $52.5M | $54.3M | $60.4M | $64.3M | $61.2M | $64.3M | $62.3M |
| Liabilities | $19.6M | $21.6M | $23.4M | $28.6M | $29.0M | $24.6M | $22.8M | $20.6M |
| Equity | $30.9M | $30.9M | $30.9M | $31.8M | $35.3M | $36.6M | $41.5M | $41.6M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $4.1M | $1.0M | $1.9M | $-4.2M | $754000 | $-173000 | $2.3M | $3.6M |